Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia

NCT05631444 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Chronic Limb-threatening Ischemia
Diabetes Mellitus

Interventions

BIOLOGICAL: Cell-based therapy

Sponsor

Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle